Popular Pre-Market Trades in U.S. Stocks
Top Gainers in U.S. Pre-Market Trading
PepGen is up 86.84% in pre-market trading. Based on recent important news:
<ol>
<li>
On September 25, PepGen announced a public offering of $100 million at a price of $3.20 per share, driving the stock price up. This move aims to fund research and clinical trials. Source: Company announcement
</li>
<li>
On September 24, PepGen released positive clinical data from its FREEDOM-DM1 study for the 15 mg/kg dosage cohort, showing an average splice correction rate of 53.7%, which significantly boosted the stock price. Source: Company announcement
</li>
<li>
On September 25, Guggenheim reiterated its buy rating on PepGen and maintained a target price of $6, further boosting market confidence. Source: Analyst report The biotechnology sector has been active recently, with significant capital inflows
</li>
</ol>

AIRE

reAlpha Tech pre-market up 8.18%; Cre8 Enterprise - CL pre-market down 7.38%; PepGen pre-market up 86.84%; WORK Medical Tech pre-market up 53.33%; OFA pre-market up 41.35%

Pre-market hot trades in US stocks: reAlpha Tech up 8.18% in pre-market; Cre8 Enterprise - CL down 7.38% in pre-market